|
|
|
|
By: Hefner (Senate Sponsor - Perry) |
H.B. No. 4888 |
|
(In the Senate - Received from the House May 10, 2023; |
|
May 11, 2023, read first time and referred to Committee on Health & |
|
Human Services; May 19, 2023, reported adversely, with favorable |
|
Committee Substitute by the following vote: Yeas 8, Nays 0; |
|
May 19, 2023, sent to printer.) |
Click here to see the committee vote |
|
|
COMMITTEE SUBSTITUTE FOR H.B. No. 4888 |
By: Perry |
|
|
A BILL TO BE ENTITLED
|
|
AN ACT
|
|
|
relating to Medicaid coverage and reimbursement for non-opioid |
|
treatments. |
|
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|
SECTION 1. Subchapter B, Chapter 32, Human Resources Code, |
|
is amended by adding Section 32.03117 to read as follows: |
|
Sec. 32.03117. REIMBURSEMENT FOR NON-OPIOID TREATMENTS. |
|
(a) In this section, "non-opioid treatment" means a drug or |
|
biological product that is indicated to produce analgesia without |
|
acting on the body's opioid receptors. |
|
(b) The commission shall ensure that medical assistance |
|
reimbursement is provided to a provider who provides a non-opioid |
|
treatment to a recipient under the medical assistance program. |
|
(c) The executive commissioner by rule shall ensure that, to |
|
the extent permitted by federal law, a hospital provider that |
|
provides outpatient department services to a medical assistance |
|
recipient is reimbursed separately under the medical assistance |
|
program for any non-opioid treatment provided as a part of those |
|
services. |
|
SECTION 2. If before implementing any provision of this Act |
|
a state agency determines that a waiver or authorization from a |
|
federal agency is necessary for implementation of that provision, |
|
the agency affected by the provision shall request the waiver or |
|
authorization and may delay implementing that provision until the |
|
waiver or authorization is granted. |
|
SECTION 3. This Act takes effect September 1, 2023. |
|
|
|
* * * * * |